We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

37 hedge funds and large institutions have $1.73M invested in Carisma Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.11% less ownership

Funds ownership: 13.47% → 13.36% (-0.11%)

10% less funds holding

Funds holding: 41 → 37 (-4)

27% less capital invested

Capital invested by funds: $2.35M → $1.73M (-$625K)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
37
Holders Change
-4
Holders Change %
-9.76%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
7
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft
Germany
+$88.6K
2
Renaissance Technologies
Renaissance Technologies
New York
+$9.88K
3
SG
StoneX Group
New York
+$4.75K
4
SWP
Stratos Wealth Partners
Ohio
+$4.43K
5
Federated Hermes
Federated Hermes
Pennsylvania
+$291

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$50.3K
2
HF
HRT Financial
New York
-$15K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$10.3K
4
UBS Group
UBS Group
Switzerland
-$9.4K
5
Goldman Sachs
Goldman Sachs
New York
-$8.95K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBP
26
Union Bancaire Privee
Switzerland
$163 – – –
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
$108 -$53 -120 -26%
PBK
28
Peoples Bank (Kansas)
Kansas
$77 – – –
IA
29
IFP Advisors
Florida
$63 – – –
CWA
30
Carolina Wealth Advisors
South Carolina
$47 – – –
OP
31
ORG Partners
Indiana
$46 – – –
Osaic Holdings
32
Osaic Holdings
Arizona
$44 – – –
SS
33
SBI Securities
Japan
$41 +$45 +102 +329%
MWA
34
Medallion Wealth Advisors
Connecticut
$31 – – –
National Bank of Canada
35
National Bank of Canada
Quebec, Canada
$16 – – –
HI
36
Harbour Investments
Wisconsin
$11 – – –
Jones Financial Companies
37
Jones Financial Companies
Missouri
$5 +$7 +16 New
Millennium Management
38
Millennium Management
New York
– -$50.3K -120,157 Closed
HF
39
HRT Financial
New York
– -$15K -36,902 Closed
Goldman Sachs
40
Goldman Sachs
New York
– -$8.95K -21,381 Closed
VF
41
Virtu Financial
New York
– -$7K -17,327 Closed
BBA
42
Baader Bank Aktiengesellschaft
Germany
– -$4.42K -11,804 Closed
TRCT
43
Tower Research Capital (TRC)
New York
– -$3.28K -7,827 Closed
Citigroup
44
Citigroup
New York
– -$4 -10 Closed
1
2

CARM Hedge Fund Activity: Q1 2025 in Review

37 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q1 2025, worth a combined $1.73M — down 27% from $2.35M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CARM and 3 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 7 added.

The largest buyer was Universal-Beteiligungs- und Servicegesellschaft, opening a new position worth an estimated $88.6K. The largest seller was Millennium Management, exiting entirely with an estimated $50.3K sold.

  • 37 institutional investors held Carisma Therapeutics (CARM) as of Q1 2025, down from 41 in Q4 2024.
  • Funds reported $1.73M of Carisma Therapeutics stock for Q1 2025, down 27% quarter-over-quarter.
  • 3 funds opened new Carisma Therapeutics positions in Q1 2025 and 7 closed out, a net change of -4 holders.
  • The largest Carisma Therapeutics buyer in Q1 2025 was Universal-Beteiligungs- und Servicegesellschaft, an estimated $88.6K added.
  • The largest Carisma Therapeutics seller in Q1 2025 was Millennium Management, an estimated $50.3K sold.

Based on aggregated 13F filings for Q1 2025.